Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Grup de Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia del Vall d’Hebron Institut de Recerca

Vall d'Hebron-led research identifies a new therapeutic strategy to treat glioblastoma

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

CB-DDT-Roser-Ferrer-Simón-Schwartz

Hyperthermic therapy with magnetic nanoparticles to improve treatment of pancreatic cancer

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

El grup de Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia del VHIR

Project-COMFORT launches to revolutionize patient-centric blood collection

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

See more

Related professionals

Ana Lain Fernandez

Ana Lain Fernandez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Liver Diseases
Read more
Laura Ludovica Gramegna .

Laura Ludovica Gramegna .

Junior researcher
Stroke research
Read more
Eva Vila Escude

Eva Vila Escude

Research technician
Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.